Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 803

1.

Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors.

Frati AC, Iniestra F, Ariza CR.

Diabetes Care. 1996 Feb;19(2):112-8.

PMID:
8718429
2.

Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.

Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.

Clin Exp Hypertens. 2001 Aug;23(6):489-500. Erratum in: Clin Exp Hypertens 2001 Nov;23(8):667.

PMID:
11478431
3.
4.
5.

Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.

Liao D, Shofer JB, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.

Diabetes Care. 2001 Jan;24(1):39-44.

PMID:
11194238
6.

Cigarette smoking, adiposity, non-insulin-dependent diabetes, and coronary heart disease in Japanese-American men.

Fujimoto WY, Leonetti DL, Bergstrom RW, Shuman WP, Wahl PW.

Am J Med. 1990 Dec;89(6):761-71.

PMID:
1979206
7.

Effects of smoking cessation on insulin and cardiovascular risk factors--a controlled study of 4 months' duration.

Nilsson P, Lundgren H, Söderström M, Fagerström KO, Nilsson-Ehle P.

J Intern Med. 1996 Oct;240(4):189-94.

PMID:
8918509
8.

Effect of breakfast fat content on glucose tolerance and risk factors of atherosclerosis and thrombosis.

Frape DL, Williams NR, Rajput-Williams J, Maitland BW, Scriven AJ, Palmer CR, Fletcher RJ.

Br J Nutr. 1998 Oct;80(4):323-31.

PMID:
9924274
9.

Increased level of hemoglobin A1c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers.

Nilsson PM, Lind L, Pollare T, Berne C, Lithell HO.

Metabolism. 1995 May;44(5):557-61.

PMID:
7752901
10.

Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study.

Braun B, Zimmermann MB, Kretchmer N, Spargo RM, Smith RM, Gracey M.

Diabetes Care. 1996 May;19(5):472-9.

PMID:
8732712
11.
12.

The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study.

Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG.

Diabetes Care. 1997 Jun;20(6):913-21.

PMID:
9167099
13.

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

Diabetes Care. 1998 May;21(5):701-5.

PMID:
9589227
14.

Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.

Ariza CR, Frati AC, Gómez G, Almazán A.

Arch Med Res. 1997 Spring;28(1):115-9.

PMID:
9078598
17.

Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance.

Hung YJ, Hsieh CH, Pei D, Kuo SW, Lee JT, Wu LY, He CT, Lee CH, Fan SC, Sheu WH.

Clin Endocrinol (Oxf). 2005 Jan;62(1):85-91.

PMID:
15638875
18.

Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.

al-Shoumer KA, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W, Johnston DG.

Clin Endocrinol (Oxf). 1998 Jun;48(6):795-802.

PMID:
9713570
19.

Serum ferritin as a component of the insulin resistance syndrome.

Fernández-Real JM, Ricart-Engel W, Arroyo E, Balançá R, Casamitjana-Abella R, Cabrero D, Fernández-Castañer M, Soler J.

Diabetes Care. 1998 Jan;21(1):62-8.

PMID:
9580307
20.

Metabolic heterogeneity in impaired glucose tolerance.

Walker M, Berrish TS, Stewart MW, Humphriss DB, Barriocanal L, Alberti KG.

Metabolism. 1997 Aug;46(8):914-7.

PMID:
9258274

Supplemental Content

Support Center